Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions

Example EvidenceVariable: Investigator

Active as of 2023-12-17

Generated Narrative: EvidenceVariable

Resource EvidenceVariable "159673" Version "12" Updated "2023-09-05 18:59:29+0000"

StructureDefinition Work Group: cds

url: https://fevir.net/resources/EvidenceVariable/159673

identifier: FEvIR Object Identifier: 159673

version: 1.0.0-ballot

name: Investigator

title: Investigator

status: active

date: 2023-12-17 16:55:23+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description: For all ANOVA and ANCOVA models, data collected from investigators who enrolled fewer than 3 patients in any one treatment group will be combined prior to analysis. If this combination still results in a treatment group having fewer than 3 patients in any one treatment group, then this group of patients will be combined with the next fewest enrolling investigator. In the event that there is a tie for fewest-enrolling investigator, one of these will be chosen at random by a random-number generator.

copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/

author: Brian S. Alper:

RelatedArtifacts

-TypeCitation
*cite-asInvestigator [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 159673. Revised 2023-09-05. Available at: https://fevir.net/resources/EvidenceVariable/159673. Computable resource at: https://fevir.net/resources/EvidenceVariable/159673.

characteristic

linkId: item0

exclude: false

DefinitionByTypeAndValues

-TypeMethodValue[x]
*identifier ()For all ANOVA and ANCOVA models, data collected from investigators who enrolled fewer than 3 patients in any one treatment group will be combined prior to analysis. If this combination still results in a treatment group having fewer than 3 patients in any one treatment group, then this group of patients will be combined with the next fewest enrolling investigator. In the event that there is a tie for fewest-enrolling investigator, one of these will be chosen at random by a random-number generator. ()Anonymous representation of investigator ()

handling: polychotomous